Roe, M.T.

patient ck-mb elevation trial ratio mortality peak ck-mb ratios 6- month mortality outcome level model treatment infarction study month category peak ck-mb ratio event heart angina pursuit nste acs surgery ck-mb levels syndrome table circulation group ck-mb elevation characteristic 6 months intervention result baseline population artery eptifibatide disease nonfatal mi periprocedural predictor gusto-iib 0.001 ck-mb elevations regression model creatine angiographic analysis heart failure <0.001 peak ck-mb categories enrolment cardiol angiography 30 days nonfatal peak creatine kinase pursuit trial peak ck-mb levels necrosis randomized /iiia investigator percutaneou st-segment >10 ln incidence heparin nonst-segment elevation acs periprocedural ck-mb elevations death nomogram paragon-b analyses baseline characteristics in-hospital systolic >10 finding enrollment